Aytu BioPharma, Inc. (AYTU)

Aytu BioPharma Income Statement

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Revenue	81.66	81	107.4	96.67	65.63	27.63
Revenue Growth (YoY)	0.41%	-24.58%	11.10%	47.29%	137.52%	277.47%
Cost of Revenue	28.77	25.69	40.77	46.39	36.43	8.28
Gross Profit	52.89	55.32	66.63	50.28	29.2	19.35
Selling, General & Admin	46.69	49.47	70.08	69.88	55.81	31.06
Research & Development	2.17	2.79	4.09	12.66	5.62	1.72
Operating Expenses	54.08	57.48	78.96	88.39	67.44	37.27
Operating Income	-1.19	-2.16	-12.33	-38.1	-38.24	-17.92
Interest Expense	-3.96	-4.79	-4.96	-0.01	-0.01	-
Other Non Operating Income (Expenses)	10.16	-3.44	4.98	0.86	-2.04	-2.6
EBT Excluding Unusual Items	5.01	-10.39	-12.32	-37.26	-40.29	-20.53
Merger & Restructuring Charges	-4.95	-3.1	-	-	-7.81	-3.02
Impairment of Goodwill	-	-	-	-65.8	-	-
Asset Writedown	-	-	-5.71	-7.66	-12.83	-0.2
Other Unusual Items	-0.59	-0.59	0.97	1.82	2.89	10.11
Pretax Income	-0.54	-14.08	-17.05	-108.89	-58.03	-13.62
Income Tax Expense	0.47	1.77	-	-0.11	0.26	-
Net Income	1.64	-15.84	-17.05	-108.78	-58.29	-13.62
Net Income to Common	1.64	-15.84	-17.05	-108.78	-58.29	-13.62
Shares Outstanding (Basic)	6	6	3	1	1	0
Shares Outstanding (Diluted)	8	6	3	1	1	0
Shares Change (YoY)	52.64%	65.81%	127.22%	75.54%	270.57%	479.80%
EPS (Basic)	0.27	-2.86	-5.11	-74.01	-69.61	-60.28
EPS (Diluted)	-0.83	-2.86	-5.11	-74.01	-69.61	-60.28
Free Cash Flow	-5.74	-1.39	-5.13	-28.82	-28.31	-28.37
Free Cash Flow Per Share	-0.73	-0.25	-1.54	-19.61	-33.80	-125.57
Gross Margin	64.77%	68.29%	62.04%	52.02%	44.49%	70.03%
Operating Margin	-1.46%	-2.67%	-11.48%	-39.42%	-58.26%	-64.86%
Profit Margin	2.01%	-19.56%	-15.88%	-112.53%	-88.81%	-49.29%
Free Cash Flow Margin	-7.03%	-1.71%	-4.78%	-29.82%	-43.13%	-102.69%
EBITDA	6	6.11	-3.51	-27.96	-29.04	-12.21
EBITDA Margin	7.35%	7.55%	-3.27%	-28.92%	-44.25%	-44.18%
D&A For EBITDA	7.19	8.27	8.82	10.15	9.2	5.71
EBIT	-1.19	-2.16	-12.33	-38.1	-38.24	-17.92
EBIT Margin	-1.46%	-2.67%	-11.48%	-39.42%	-58.26%	-64.86%
Advertising Expenses	-	4.88	17.22	13.6	15.2	4.7

Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q